Colm Morrissey

17.9k citations

147 papers · 7.4k · 2 hit papers · h-index 48

Impact in

Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research

Papers in

Pulmonary and Respiratory Medicine 81
- Prostate Cancer Treatment and Research 78
Molecular Biology 54
- Cancer-related gene regulation 9
- FOXO transcription factor regulation 7

Co-authors: Robert L. Vessella (42 shared papers)Peter S. Nelson (61 shared papers)Ilsa M. Coleman (38 shared papers)Lawrence D. True (38 shared papers)Eva Corey (49 shared papers)Celestia S. Higano (16 shared papers)Xiaotun Zhang (18 shared papers)Martine P. Roudier (21 shared papers)
Journals: The Prostate (15 papers)Cancer Research (14 papers)Clinical Cancer Research (8 papers)Nature Communications (6 papers)PLoS ONE (5 papers)
Partner nations: United States Ireland South Africa

In The Last Decade

Colm Morrissey

142 papers receiving 7.3k citations

Colm Morrissey's Hit Papers

align trajectories log scale

The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis 2014 · 344 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Cancer Discovery
2014 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Colm Morrissey

Since Specialization

Citations

This map shows the geographic impact of Colm Morrissey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colm Morrissey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colm Morrissey more than expected).

Fields of papers citing papers by Colm Morrissey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colm Morrissey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colm Morrissey. The network helps show where Colm Morrissey may publish in the future.

Co-authors

The 25 scholars most cited alongside Colm Morrissey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Colm Morrissey Line = papers co-authored together Colm Morrissey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Quantitative and stoichiometric analysis of the microRNA content of exosomes Proceedings of the National Academy of Sciences ·John R. Chevillet, Qing Kang, Ingrid K. Ruf, Hilary Briggs, Lucia Vojtech, Sean M. Hughes, Heather H. Cheng, Jason D. Arroyo, Emily Meredith, Emily N. Gallichotte, Era L. Pogosova‐Agadjanyan, Colm Morrissey, Derek L. Stirewalt, Florian Hladik, Evan Y. Yu, Celestia S. Higano, Muneesh Tewari Hit paper breakdown →	2014	895
2	The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis Cancer Discovery ·Jared M. Lucas, Cynthia Heinlein, Tom Kim, Susana Hernández, Muzdah S. Malik, Lawrence D. True, Colm Morrissey, Eva Corey, Bruce Montgomery, Elahe A. Mostaghel, Nigel Clegg, Ilsa M. Coleman, Christopher M. Brown, Eric L. Schneider, Charles S. Craik, Julian A. Simon, Antonio Bedalov, Peter S. Nelson Hit paper breakdown →	2014	344
3	NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes Nature Communications ·María Soledad Sosa, Falguni Parikh, Alexandre Gaspar‐Maia, Yeriel Estrada, Almudena Bosch, Paloma Bragado, Esther Ekpin, Ajish George, Yang Zheng, Hung‐Ming Lam, Colm Morrissey, Chi-Yeh Chung, Eduardo Farias, Emily Bernstein, Julio A. Aguirre‐Ghiso	2015	264
4	The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression Journal of Clinical Investigation ·Ankur Sharma, Wen-Shuz Yeow, Adam Ertel, Ilsa M. Coleman, Nigel Clegg, Chellappagounder Thangavel, Colm Morrissey, Xiaotun Zhang, Clay E.S. Comstock, Agnieszka K. Witkiewicz, Leonard G. Gomella, Erik S. Knudsen, Peter S. Nelson, Karen E. Knudsen	2010	255
5	Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer Nature Communications ·Colin C. Pritchard, Colm Morrissey, Akash Kumar, Xiaotun Zhang, Christina Smith, Ilsa M. Coleman, Stephen J. Salipante, Jennifer H. Milbank, Ming Yu, William M. Grady, Jonathan F. Tait, Eva Corey, Robert L. Vessella, Tom Walsh, Jay Shendure, Peter S. Nelson	2014	201
6	Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases PLoS ONE ·Xiaotun Zhang, Colm Morrissey, Shihua Sun, Melanie Ketchandji, Peter S. Nelson, Lawrence D. True, Funda Vakar‐Lopez, Robert L. Vessella, Stephen R. Plymate	2011	200
7	Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers Proceedings of the National Academy of Sciences ·Akash Kumar, Thomas A. White, Alexandra P MacKenzie, Nigel Clegg, Choli Lee, Ruth F. Dumpit, Ilsa M. Coleman, Sarah Ng, Stephen J. Salipante, Mark J. Rieder, Deborah A. Nickerson, Eva Corey, Paul H. Lange, Colm Morrissey, Robert L. Vessella, Peter S. Nelson, Jay Shendure	2011	192
8	LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics The Prostate ·Holly M. Nguyen, Robert L. Vessella, Colm Morrissey, Lisha G. Brown, Ilsa M. Coleman, Celestia S. Higano, Elahe A. Mostaghel, Xiaotun Zhang, Lawrence D. True, Hung‐Ming Lam, Martine P. Roudier, Paul H. Lange, Peter S. Nelson, Eva Corey	2017	185
9	Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling Nature Communications ·Lauren Brady, Michelle Kriner, Ilsa M. Coleman, Colm Morrissey, Martine P. Roudier, Lawrence D. True, Roman Gulati, Stephen R. Plymate, Zoey Zhou, Brian Birditt, Rhonda Meredith, Gary Geiss, Margaret L. Hoang, Joseph Beechem, Peter S. Nelson	2021	169
10	Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress Cell Reports ·Michael D. Nyquist, Alexandra Corella, Ilsa M. Coleman, Navonil De Sarkar, Arja Kaipainen, Gavin Ha, Roman Gulati, Lisa S. Ang, Payel Chatterjee, Jared M. Lucas, Colin C. Pritchard, Gail P. Risbridger, John T. Isaacs, Bruce Montgomery, Colm Morrissey, Eva Corey, Peter S. Nelson	2020	168
11	Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia PLoS ONE ·Heather H. Cheng, Patrick S. Mitchell, Evan M. Kroh, Alexander E. Dowell, Lisly Chéry, Javed Siddiqui, Peter S. Nelson, Robert L. Vessella, Beatrice S. Knudsen, Arul M. Chinnaiyan, Kenneth J. Pienta, Colm Morrissey, Muneesh Tewari	2013	154
12	SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer Clinical Cancer Research ·Xiaotun Zhang, Ilsa M. Coleman, Lisha G. Brown, Lawrence D. True, Lori Kollath, Jared M. Lucas, Hung‐Ming Lam, Ruth F. Dumpit, Eva Corey, Lisly Chéry, Bryce Lakely, Celestia S. Higano, Bruce Montgomery, Martine P. Roudier, Paul H. Lange, Peter S. Nelson, Robert L. Vessella, Colm Morrissey	2015	129
13	Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer Nature Communications ·Christine Henzler, Yingming Li, Rendong Yang, Terri D. McBride, Yeung Ho, Cynthia C.T. Sprenger, Gang Liu, Ilsa M. Coleman, Bryce Lakely, Rui Li, Shihong Ma, Sean R. Landman, Vipin Kumar, Tae Hyun Hwang, Ganesh V. Raj, Celestia S. Higano, Colm Morrissey, Peter S. Nelson, Stephen R. Plymate, Scott M. Dehm	2016	120
14	Metastatic Progression of Prostate Cancer and E-Cadherin American Journal Of Pathology ·Aaron P. Putzke, Aviva P. Ventura, Alexander M. Bailey, Canan Akture, John Opoku‐Ansah, Müge Çeliktaş, Michael S. Hwang, Douglas S. Darling, Ilsa M. Coleman, Peter S. Nelson, Holly M. Nguyen, Eva Corey, Muneesh Tewari, Colm Morrissey, Robert L. Vessella, Beatrice S. Knudsen	2011	117
15	Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression Journal of Clinical Investigation ·Bing Song, Su-Hong Park, Jonathan C. Zhao, Ka-wing Fong, Shangze Li, Yongik Lee, Yeqing Angela Yang, Subhasree Sridhar, Xiaodong Lü, Sarki A. Abdulkadir, Robert L. Vessella, Colm Morrissey, Timothy M. Kuzel, William J. Catàlona, Ximing J. Yang, Jindan Yu	2018	111
16	Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases The Journal of Urology ·Martine P. Roudier, Colm Morrissey, Lawrence D. True, Celestia S. Higano, Robert L. Vessella, Susan M. Ott	2008	110
17	The androgen‐regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma The Journal of Pathology ·JM LUCAS, Lawrence D. True, Sarah Hawley, Masazumi Matsumura, Colm Morrissey, R L Vessella, PS Nelson	2008	98
18	Clusterin Biogenesis Is Altered during Apoptosis in the Regressing Rat Ventral Prostate Journal of Biological Chemistry ·Johnathan N. Lakins, Steffany A. L. Bennett, Jia-Hua Chen, Jennifer M. Arnold, Colm Morrissey, Paul Wong, Jacintha O’Sullivan, Martin Tenniswood	1998	98
19	ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors Cancer Cell ·Liem T. Nguyen, Maria Tretiakova, Mark R. Silvis, Jared M. Lucas, Olga Klezovitch, Ilsa M. Coleman, Hamid Bolouri, Vassily I. Kutyavin, Colm Morrissey, Lawrence D. True, Peter S. Nelson, Valeri Vasioukhin	2015	95
20	Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer Cancer Research ·Shangze Li, Ka-wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Adam Sharp, Wei Yuan, Caterina Aversa, Ximing J. Yang, Peter S. Nelson, Felix Y. Feng, Arul M. Chinnaiyan, Johann S. de Bono, Colm Morrissey, Matthew B. Rettig, Jindan Yu	2019	93

About Colm Morrissey

Colm Morrissey is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Immunology, having authored 147 papers that have together received 7.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (78 papers), Bone health and treatments (15 papers), Cancer Cells and Metastasis (10 papers), Cell Adhesion Molecules Research (10 papers), Cancer-related gene regulation (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), FOXO transcription factor regulation (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Cancer Research (2.2k citations), Pulmonary and Respiratory Medicine (2.6k citations), Oncology (1.9k citations), Molecular Biology (3.4k citations) and Immunology and Allergy (164 citations). Colm Morrissey has collaborated with scholars based in United States, Ireland and South Africa. Frequent co-authors include Robert L. Vessella, Peter S. Nelson, Ilsa M. Coleman, Lawrence D. True, Eva Corey, Celestia S. Higano, Xiaotun Zhang, Martine P. Roudier, R. William G. Watson and Paul H. Lange. Their work appears in journals such as The Prostate, Cancer Research, Clinical Cancer Research, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Colm Morrissey

Impact in

Papers in i

In The Last Decade

Colm Morrissey

Colm Morrissey's Hit Papers

Peers

Countries citing papers authored by Colm Morrissey

Fields of papers citing papers by Colm Morrissey

All Works

About Colm Morrissey

Explore authors with similar magnitude of impact

Papers in